[Ferroptosis and liver diseases]. [PDF]
Li X +5 more
europepmc +1 more source
[Discussion on the design approach and results evaluation key points of repeated exposure systemic toxicity tests for absorbable medical devices]. [PDF]
Fan C +5 more
europepmc +1 more source
[Research progress of inherited metabolic liver disease in 2024]. [PDF]
Hou W, Duan ZP, Zheng SJ.
europepmc +1 more source
[Bushen Yijing Formula attenuates amyloid β-protein deposi-tion and oxidative damage in <i>Caenorhabditis elegans</i>]. [PDF]
Lu Y, Li D, Hu Y, Lu L, Yu G.
europepmc +1 more source
[Mechanisms of gut<b>-</b>derived trimethylamine<b>-</b>N<b>-</b>oxide in mediating multiple organ injury in post<b>-</b>cardiac arrest syndrome]. [PDF]
Gong X, Chen S, Zhang T, Wang A, Mo X.
europepmc +1 more source
[Analysis of urine biomarkers in urothelial carcinoma based on untargeted metabolomics]. [PDF]
Liu S, Wang M, Wang W.
europepmc +1 more source
[Research progress on clinical characteristics and pathological mechanisms of lean metabolic-associated fatty liver disease]. [PDF]
He N +5 more
europepmc +1 more source
[Research progress on the role of ferroptosis in aortic dissection]. [PDF]
Hong X, Zhang Y, Fu W, Wang L.
europepmc +1 more source
[Applications and Advances of Metabolomics in Lung Cancer Research]. [PDF]
Wang D +8 more
europepmc +1 more source

